• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然来源的降脂药物:一些有前途的化学型的描述。

Lipid lowering agents of natural origin: An account of some promising chemotypes.

机构信息

Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India.

Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India.

出版信息

Eur J Med Chem. 2017 Nov 10;140:331-348. doi: 10.1016/j.ejmech.2017.09.020. Epub 2017 Sep 14.

DOI:10.1016/j.ejmech.2017.09.020
PMID:28987600
Abstract

The role of natural products in the drug development and discovery has been phenomenal. There has been an enormous interest in exploring all possible natural sources to identify structures exhibiting pronounced hypolipidemic activity albeit with no toxicity. The present review describes the profile of some interesting naturally occurring compounds and their derivatives as potential hypolipidemic agents. Some of the interesting natural chemotypes that can control the increased levels of plasma lipids and discussed in this review are compactin, lovastatin, gugglesterone, berberine, lupeol, phytol, polyprenol, aegeline, 4-hydroxyisoleucine, α-asarone, resveratrol, esculeoside A, swertiamarin, rutin, saucerneol B, curcumin and a clerodane diterpene.

摘要

天然产物在药物开发和发现中的作用是惊人的。人们对探索所有可能的天然来源产生了浓厚的兴趣,以确定具有显著降血脂活性且无毒的结构。本综述描述了一些具有潜在降血脂作用的有趣天然化合物及其衍生物的概况。本文综述了一些可以控制血浆脂质水平升高的有趣天然化学型,如考来烯胺、洛伐他汀、gugglesterone、小檗碱、羽扇豆醇、植醇、多聚异戊烯、aegeline、4-羟基异亮氨酸、α-细辛脑、白藜芦醇、 Esculeoside A、苦玄参苷 I、芦丁、香叶醇 B、姜黄素和 clerodane 二萜。

相似文献

1
Lipid lowering agents of natural origin: An account of some promising chemotypes.天然来源的降脂药物:一些有前途的化学型的描述。
Eur J Med Chem. 2017 Nov 10;140:331-348. doi: 10.1016/j.ejmech.2017.09.020. Epub 2017 Sep 14.
2
[Combined treatment: regimens, indications and safety profile].联合治疗:方案、适应证及安全性概况
Clin Investig Arterioscler. 2013 Jul-Aug;25(3):140-5. doi: 10.1016/j.arteri.2013.06.003. Epub 2013 Jul 21.
3
Lipid-modifying effects of nutraceuticals: An evidence-based approach.营养保健品的脂质调节作用:循证方法
Nutrition. 2016 Nov-Dec;32(11-12):1179-92. doi: 10.1016/j.nut.2016.04.007. Epub 2016 May 17.
4
Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review.胆汁酸螯合剂在血脂异常治疗中的临床应用:一项科学综述。
South Med J. 2006 Mar;99(3):257-73. doi: 10.1097/01.smj.0000208120.73327.db.
5
[Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents].[心血管并发症的残余风险及其通过联合降脂药物降低的情况]
Vnitr Lek. 2011 Mar;57(3):313-6.
6
Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review.阿托伐他汀联合烟酸治疗可有效控制复杂血脂异常:文献复习。
Postgrad Med. 2012 Jan;124(1):7-20. doi: 10.3810/pgm.2012.01.2513.
7
[Multimodal therapy of dyslipidemia].[血脂异常的多模式治疗]
Clin Res Cardiol Suppl. 2011 May;6:10-6. doi: 10.1007/s11789-011-0031-5.
8
Optimal pharmacotherapy to combat the atherogenic lipid triad.优化药物治疗以对抗致动脉粥样硬化脂质三联征。
Curr Opin Cardiol. 2011 Sep;26(5):403-11. doi: 10.1097/HCO.0b013e32834965e9.
9
Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis.他汀类药物单独治疗和联合贝特类药物治疗血脂异常患者的安全性和疗效:一项荟萃分析。
Curr Med Res Opin. 2014 Jan;30(1):1-10. doi: 10.1185/03007995.2013.842165. Epub 2013 Oct 1.
10
Combination lipid therapy in type 2 diabetes mellitus.2 型糖尿病的联合脂质治疗。
Expert Opin Pharmacother. 2011 Jun;12(9):1393-403. doi: 10.1517/14656566.2011.558503. Epub 2011 Feb 16.

引用本文的文献

1
Bioactive Potential and Health Benefits of L.: A Comprehensive Review.L.的生物活性潜力与健康益处:综述
Food Sci Nutr. 2025 Sep 5;13(9):e70887. doi: 10.1002/fsn3.70887. eCollection 2025 Sep.
2
Progress in Pharmacokinetics, Pharmacological Effects, and Molecular Mechanisms of Swertiamarin: A Comprehensive Review.獐牙菜苦苷的药代动力学、药理作用及分子机制研究进展:综述
Cells. 2025 Jul 30;14(15):1173. doi: 10.3390/cells14151173.
3
Phytyl Phenolipids: Structurally Modified Antioxidants with Superior Lipid Membrane Interaction.
植基酚脂质:具有卓越脂质膜相互作用的结构修饰抗氧化剂。
Molecules. 2025 May 17;30(10):2193. doi: 10.3390/molecules30102193.
4
Deciphering agronomic traits, biochemical components, and color in unique green-seeded fenugreek ( L.) genotypes.解析独特绿籽胡芦巴(L.)基因型的农艺性状、生化成分和颜色。
Front Nutr. 2025 Feb 27;12:1542211. doi: 10.3389/fnut.2025.1542211. eCollection 2025.
5
Cholesterol-rich lysosomes induced by respiratory syncytial virus promote viral replication by blocking autophagy flux.呼吸道合胞病毒诱导富含胆固醇的溶酶体通过阻断自噬流促进病毒复制。
Nat Commun. 2024 Jul 26;15(1):6311. doi: 10.1038/s41467-024-50711-4.
6
Berberine attenuates brain aging via stabilizing redox homeostasis and inflammation in an accelerated senescence model of Wistar rats.小檗碱通过稳定氧化还原平衡和减轻炎症来减轻 Wistar 大鼠加速衰老模型的脑老化。
Metab Brain Dis. 2024 Jun;39(5):649-659. doi: 10.1007/s11011-024-01350-7. Epub 2024 May 10.
7
A review of the role of liposome-encapsulated phytochemicals targeting PPAR Ɣ and associated pathways to combat obesity.脂质体包裹的植物化学物质靶向过氧化物酶体增殖物激活受体γ及相关途径对抗肥胖作用的综述
3 Biotech. 2023 Sep;13(9):313. doi: 10.1007/s13205-023-03740-7. Epub 2023 Aug 24.
8
The Beneficial Effects of Curcumin on Lipids: Possible Effects on Dyslipidemia-induced Cardiovascular Complications.姜黄素对血脂的有益作用:对血脂异常引起的心血管并发症的可能影响。
Curr Med Chem. 2024;31(42):6957-6970. doi: 10.2174/0929867331666230707094644.
9
The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage.法呢醇和香叶基香叶醇回收途径缺失的生物医学重要性。
Molecules. 2022 Dec 8;27(24):8691. doi: 10.3390/molecules27248691.
10
Sea cucumber-derived compounds for treatment of dyslipidemia: A review.用于治疗血脂异常的海参衍生化合物:综述
Front Pharmacol. 2022 Sep 14;13:1000315. doi: 10.3389/fphar.2022.1000315. eCollection 2022.